PGCX, PanGenex Expands Clinical Trial Sites after Promising Pre-Clinical Data about Lower Coronary Arterial Calcium Scores in Cardiac Patients
Dr. Stock Pick (November 18th, 2009) Writes:
Dr Stock Pick HOT News & Alerts!
_________________________________________
FREE Daily Stock Alerts From DrStockPick.com
_________________________________________
Wednesday November 18, 2009
DrStockPick.com Stock Report!
PGCX, Pangenex Corporation, PGCX.PK
**************************************************************
PanGenex Expands Clinical Trial Sites after Promising Pre-Clinical Data about Lower Coronary Arterial Calcium Scores in Cardiac Patients
TAMPA, Fla.–(CRWENEWSWIRE -Nov 18, 2009)–PanGenex Corporation (Pink Sheets: PGCX) (“PanGenex” or “the Company”) announced that due to promising pre-clinical results from its clinical trial at the Cardiovascular Institute of the South (http://www.cardio.com/site1.php), the Company will extend its trial to two additional sites.
The Company initiated a 100 patient, placebo based, double blind clinical trial at the CardioVascular Institute of the South. Early results
...

![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/silver/t24_ag_en_usoz_2.gif)



Power3 Medical Products, Inc.
